COIN vs TARS · P/E 64, rev $2.63B vs rev $336.0M
Coinbase Global Inc (COIN) versus Tarsus Pharmaceuticals Inc (TARS) — a side-by-side from cached financials, not a winner call.
Coinbase Global Inc (COIN) is a financial data & stock exchanges company listed on US. It is led by Brian Armstrong.
Tarsus Pharmaceuticals Inc (TARS) is a biotechnology company listed on NASDAQ.
Latest reported COIN revenue for 2026-06-30 was $2.63B. Net income was -$753.6M. Revenue was up 86.3% from 2026-03-31 to 2026-06-30. COIN currently screens at market cap $45.84B and trailing P/E 64.2.
Latest reported TARS revenue for 2026-06-30 was $336.0M. Net income was -$25.5M. TARS currently screens at market cap $2.66B.
COIN currently screens at market cap $45.84B and trailing P/E 64.2. TARS currently screens at market cap $2.66B.
Not investment advice. Open the COIN and TARS stock pages for the full models.
Not investment advice.